Asia-Pacific Veterinary Pain Management Market - Industry Trends and Forecast to 2031
Market Report I 2023-09-01 I 229 Pages I Data Bridge Market Research
Asia-Pacific veterinary pain management market is expected to reach USD 586,635.95 thousand by 2030 from USD 409,355.09 thousand in 2022 growing at a CAGR of 4.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
Asia Pacific Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Taiwan, Vietnam, and rest of Asia-Pacific) - Industry Trends and Forecast to 2030
Overview of Asia Pacific Veterinary Pain Management Market Dynamics
Driver
- Rising incidences of pet diseases
Restraint
- High costs of pet care
Opportunity
- Technological advancements for pain management
Market Players
Some of the major market players operating in the Asia-Pacific veterinary pain management market are:
- Dechra Pharmaceuticals PLC
- Virbac
- Norbrook
- Bimeda, Inc.
- Inovet ( A subsidiary of Orion Group)
- Chanelle Pharma
- Vetoquinol
- Elanco
- Merck & Co., Inc.
- Ceva Animal Health, LLC
TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET 26
1.4 CURRENCY AND PRICING 28
1.5 LIMITATIONS 28
1.6 MARKETS COVERED 29
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 DBMR TRIPOD DATA VALIDATION MODEL 35
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.6 MULTIVARIATE MODELLING 39
2.7 MARKET END USER COVERAGE GRID 39
2.8 PRODUCT LIFELINE CURVE 40
2.9 DBMR MARKET POSITION GRID 41
2.10 VENDOR SHARE ANALYSIS 42
2.11 SECONDARY SOURCES 43
2.12 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTER'S FIVE FORCES 49
4.3 BRAND REVENUE ANALYSIS 50
5 MARKET OVERVIEW 51
5.1 DRIVERS 53
5.1.1 INCREASING PET OWNERSHIP 53
5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 53
5.1.3 GROWING INCIDENCES OF PET DISEASES 54
5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 54
5.2 RESTRAINTS 55
5.2.1 INCREASING PET CARE COSTS 55
5.2.2 STRICT REGULATORY GUIDELINES 55?
5.3 OPPORTUNITIES 56
5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 56
5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 57
5.3.3 TECHNOLOGICAL ADVANCEMENTS 57
5.4 CHALLENGES 58
5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 58
5.4.2 RESISTANCE TO MEDICATIONS 58
6 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 59
6.1 OVERVIEW 60
6.2 ANALGESICS 61
6.2.1 ANTI- INFLAMMATORY (NSAIDS) 61
6.2.1.1 CARPROFEN 62
6.2.1.2 MELOXICAM 62
6.2.1.3 PHENYLBUTAZONE 62
6.2.1.4 ACETAMINOPHEN 62
6.2.1.5 FIROCOXIB 62
6.2.1.6 DERACOXIB 62
6.2.1.7 OTHERS 63
6.2.2 OPIOIDS 63
6.2.2.1 MU AGONISTS 63
6.2.2.1.1 METHADONE 64
6.2.2.1.2 MEPERIDINE 64
6.2.2.1.3 MORPHINE 64
6.2.2.1.4 OXYMORPHONE 64
6.2.2.1.5 OTHERS 64
6.2.2.2 PARTIAL MU AGONIST 64
6.2.2.2.1 BUPRENORPHINE 64
6.2.2.2.2 OTHERS 65
6.2.2.3 KAPPA AGONIST MU ANTAGONIST 65
6.2.2.3.1 BUTORPHANOL 65
6.2.2.3.2 OTHERS 65
6.3 CORTICOSTEROIDS 66
6.3.1 DEXAMETHASONE 66
6.3.2 PREDNISOLONE 66
6.3.3 PREDNISONE 66
6.3.4 OTHERS 67
6.4 ALPHA 2 AGONISTS 67?
7 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 68
7.1 OVERVIEW 69
7.2 BRANDED 70
7.3 GENERIC 70
8 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 71
8.1 OVERVIEW 72
8.2 PRESCRIPTION BASED 73
8.3 OTC 73
9 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 74
9.1 OVERVIEW 75
9.2 COMPANION ANIMAL 76
9.2.1 CANINE 77
9.2.2 EQUINE 77
9.2.3 FELINE 77
9.2.4 OTHERS 77
9.3 PRODUCTION ANIMAL 77
9.3.1 CATTLE 78
9.3.2 SWINE 78
9.3.3 POULTRY 78
9.3.4 FISH 78
9.3.5 OTHERS 78
10 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 79
10.1 OVERVIEW 80
10.2 CHRONIC PAIN 81
10.3 ACUTE PAIN 82
10.4 POST OPERATIVE PAIN 82
10.5 DENTAL PAIN 83
11 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 84
11.1 OVERVIEW 85
11.2 SOLID 86
11.2.1 TABLET 86
11.2.2 POWDER 87
11.2.3 OTHERS 87?
11.3 LIQUID 87
11.3.1 SOLUTION 87
11.3.2 SYRUP 88
11.3.3 SUSPENSION 88
11.3.4 OTHERS 88
11.4 SEMI SOLID 88
11.4.1 GEL 89
11.4.2 CREAM 89
11.4.3 OTHERS 89
12 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 90
12.1 OVERVIEW 91
12.2 PARENTERAL 92
12.3 ORAL 93
12.4 TOPICAL 93
13 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER 94
13.1 OVERVIEW 95
13.2 VETERINARY HOSPITALS 96
13.3 VETERINARY CLINICS 97
13.4 PET SHOPS 97
13.5 ANIMAL FARMS 98
13.6 ACADEMIC & RESEARCH INSTITUTES 98
13.7 OTHERS 99
14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 100
14.1 ASIA PACIFIC 101
14.1.1 CHINA 109
14.1.2 AUSTRALIA 116
14.1.3 INDIA 123
14.1.4 JAPAN 130
14.1.5 SINGAPORE 137
14.1.6 INDONESIA 144
14.1.7 MALAYSIA 151
14.1.8 NEW ZEALAND 158
14.1.9 SOUTH KOREA 165
14.1.10 VIETNAM 172
14.1.11 THAILAND 179
14.1.12 PHILIPPINES 186
14.1.13 TAIWAN 193
14.1.14 REST OF ASIA-PACIFIC 200
15 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 201
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 201
16 SWOT ANALYSIS 202
17 COMPANY PROFILE 203
17.1 ZOETIS SERVICES LLC 203
17.1.1 COMPANY SNAPSHOT 203
17.1.2 COMPANY SHARE ANALYSIS 203
17.1.3 PRODUCT PORTFOLIO 204
17.1.4 RECENT DEVELOPMENTS 204
17.2 ELANCO 205
17.2.1 COMPANY SNAPSHOT 205
17.2.2 REVENUE ANALYSIS 205
17.2.3 COMPANY SHARE ANALYSIS 206
17.2.4 PRODUCT PORTFOLIO 206
17.2.5 RECENT DEVELOPMENT 206
17.3 MERCK & CO., INC. 207
17.3.1 COMPANY SNAPSHOT 207
17.3.2 REVENUE ANALYSIS 207
17.3.3 COMPANY SHARE ANALYSIS 208
17.3.4 PRODUCT PORTFOLIO 208
17.3.5 RECENT DEVELOPMENT 208
17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 209
17.4.1 COMPANY SNAPSHOT 209
17.4.2 COMPANY SHARE ANALYSIS 209
17.4.3 PRODUCT PORTFOLIO 210
17.4.4 RECENT DEVELOPMENT 210
17.5 VETOQUINOL 211
17.5.1 COMPANY SNAPSHOT 211
17.5.2 REVENUE ANALYSIS 211
17.5.3 COMPANY SHARE ANALYSIS 212
17.5.4 PRODUCT PORTFOLIO 212
17.5.5 RECENT DEVELOPMENTS 212
17.6 BIMEDA, INC. 214
17.6.1 COMPANY SNAPSHOT 214
17.6.2 PRODUCT PORTFOLIO 214
17.6.3 RECENT DEVELOPMENT 214?
17.7 CEVA ANIMAL HEALTH, LLC 215
17.7.1 COMPANY SNAPSHOT 215
17.7.2 PRODUCT PORTFOLIO 215
17.7.3 RECENT DEVELOPMENT 215
17.8 CHANELLE PHARMA 216
17.8.1 COMPANY SNAPSHOT 216
17.8.2 PRODUCT PORTFOLIO 216
17.8.3 RECENT DEVELOPMENT 216
17.9 DECHRA PHARMACEUTICALS PLC 217
17.9.1 COMPANY SNAPSHOT 217
17.9.2 REVENUE ANALYSIS 217
17.9.3 PRODUCT PORTFOLIO 218
17.9.4 RECENT DEVELOPMENTS 218
17.10 DURVET ANIMAL HEALTH PRODUCTS 219
17.10.1 COMPANY SNAPSHOT 219
17.10.2 PRODUCT PORTFOLIO 219
17.10.3 RECENT DEVELOPMENT 219
17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 220
17.11.1 COMPANY SNAPSHOT 220
17.11.2 PRODUCT PORTFOLIO 220
17.11.3 RECENT DEVELOPMENTS 220
17.12 NORBROOK 222
17.12.1 COMPANY SNAPSHOT 222
17.12.2 PRODUCT PORTFOLIO 222
17.12.3 RECENT DEVELOPMENT 222
17.13 VIRBAC 223
17.13.1 COMPANY SNAPSHOT 223
17.13.2 REVENUE ANALYSIS 223
17.13.3 PRODUCT PORTFOLIO 224
17.13.4 RECENT DEVELOPMENT 224
18 QUESTIONNAIRE 225
19 RELATED REPORTS 229
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.